Results 251 to 260 of about 8,994,995 (387)
Calling on and thanking God: the role of faith and faith communities in disaster recovery. [PDF]
Storr VH, Lofthouse JK, Storr NM.
europepmc +1 more source
Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma
GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski+19 more
wiley +1 more source
Compliance and coloniality: aid bureaucracy and the failures of 'localisation' in Myanmar's complex emergency. [PDF]
Décobert A, Maung PP, Scott A, Wells T.
europepmc +1 more source
Inhibition of SV40 gene expression by microinjected sma antisense RNA and DNA molecules
M. Graessmann+3 more
openalex +2 more sources
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau+9 more
wiley +1 more source
Feasibility and Preliminary Efficacy of the Biya Yadha Gudjagang Yadha: Healthy Dads Healthy Mob Program. [PDF]
MacDonald JC+6 more
europepmc +1 more source
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp+13 more
wiley +1 more source
A Qualitative Exploration of Food Insecurity and Institutional Support Among International Students at a Regional Australian University. [PDF]
Leung KM+5 more
europepmc +1 more source
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald+18 more
wiley +1 more source